Published in Appl Environ Microbiol on January 01, 2001
Amino acid metabolism in mammalian cell cultures. Science (1959) 55.21
Growth of several cariogenic strains of oral streptococci in a chemically defined medium. Infect Immun (1975) 9.48
Group B streptococcal disease in the era of intrapartum antibiotic prophylaxis. N Engl J Med (2000) 6.58
Rapid recognition of group-B Streptococci. Lancet (1977) 3.42
Identification of genetic determinants for the hemolytic activity of Streptococcus agalactiae by ISS1 transposition. J Bacteriol (1999) 1.95
New Granada Medium for detection and identification of group B streptococci. J Clin Microbiol (1992) 1.84
Characterization and incidence of pigment production by human clinical group B streptococci. J Clin Microbiol (1978) 1.74
Use of Granada medium to detect group B streptococcal colonization in pregnant women. J Clin Microbiol (1999) 1.64
Improved medium for detecting pigment production by group B streptococci. J Clin Microbiol (1976) 1.61
Growth and amino acid requirements of various strains of group B streptococci. J Clin Microbiol (1978) 1.47
Pigment production by Lancefield-group-B streptococci (Streptococcus agalactiae). J Med Microbiol (1986) 1.44
Granada medium for detection and identification of group B streptococci. J Clin Microbiol (1983) 1.41
Long-chain fatty acid inhibition of growth of Streptococcus agalactiae in a chemically defined medium. J Bacteriol (1966) 1.39
Relationship between pigment production and haemolysin formation by Lancefield group B streptococci. J Med Microbiol (1987) 1.07
Identification of serum and urine proteins responsible for enhanced pigment production by group B streptococci as amylases. Clin Diagn Lab Immunol (1996) 1.06
Effects of nutritional characteristics of Streptococcus agalactiae on inhibition of growth by lactoperoxidase-thiocyanate-hydrogen peroxide in chemically defined culture medium. Appl Environ Microbiol (1976) 1.04
Identification of a peptide from mammal albumins responsible for enhanced pigment production by group B streptococci. Clin Diagn Lab Immunol (1999) 0.89
Isolation and expansion of the catabolic potential of a Pseudomonas putida strain able to grow in the presence of high concentrations of aromatic hydrocarbons. J Bacteriol (1995) 2.38
Mechanisms for solvent tolerance in bacteria. J Biol Chem (1997) 1.99
Use of Granada medium to detect group B streptococcal colonization in pregnant women. J Clin Microbiol (1999) 1.64
Timing of intrapartum ampicillin and prevention of vertical transmission of group B streptococcus. Obstet Gynecol (1998) 1.23
Mutation analysis of the p53, APC, and p16 genes in the Barrett's oesophagus, dysplasia, and adenocarcinoma. J Clin Pathol (1997) 1.13
Metabolism of nitrate esters by a consortium of two bacteria. Nat Biotechnol (1996) 1.08
Identification of serum and urine proteins responsible for enhanced pigment production by group B streptococci as amylases. Clin Diagn Lab Immunol (1996) 1.06
New chromosomal regions with high-level amplifications in squamous cell carcinomas of the larynx and pharynx, identified by comparative genomic hybridization. J Pathol (2001) 0.96
Isolation of Mycoplasma hominis from extragenital cultures. Eur J Clin Microbiol Infect Dis (2005) 0.96
Right-sided endocarditis complicating an atrial septal defect. Am J Med Sci (2003) 0.90
Identification of a peptide from mammal albumins responsible for enhanced pigment production by group B streptococci. Clin Diagn Lab Immunol (1999) 0.89
Selection and preliminary characterization of a Pseudomonas aeruginosa strain mineralizing selected isomers in a branchedchain dodecylbenzenesulphonate mixture. World J Microbiol Biotechnol (1996) 0.88
Modification of immune response in mice by ciprofloxacin. Antimicrob Agents Chemother (1995) 0.88
Efficacy of a universal screening program for the prevention of neonatal group B streptococcal disease. Eur J Clin Microbiol Infect Dis (1995) 0.87
In vivo construction of a hybrid pathway for metabolism of 4-nitrotoluene in Pseudomonas fluorescens. J Bacteriol (1997) 0.87
Influence of dietary nucleotides on plasma immunoglobulin levels and lymphocyte subsets of preterm infants. Biofactors (1999) 0.87
PET imaging of thymidine kinase gene expression in the liver of non-human primates following systemic delivery of an adenoviral vector. Gene Ther (2008) 0.84
Pleomorphic adenoma of the salivary glands: prospective clinicopathologic and flow cytometric study. Head Neck (1999) 0.83
Immunomodulation in mice by experimental infection with Yersinia enterocolitica. Microbiol Immunol (1985) 0.80
Circulating IgG response to stromelysin-3, collagenase-3, galectin-3 and mesothelin in patients with pharynx/larynx squamous cell carcinoma. Anticancer Res (2002) 0.80
Influence of the culture medium on the expression of surface polypeptides of Yersinia enterocolitica. Curr Microbiol (1995) 0.80
Immunofluorometric assay of pepsinogen C and preliminary clinical applications. Clin Chem (1997) 0.78
Diagnostic accuracy of the cytologic diagnosis of anal human papillomavirus infection compared with DNA hybridization studies. Sex Transm Dis (1993) 0.78
Chromosome-mediated resistance of Yersinia enterocolitica serotype O9 to intracellular killing by mouse peritoneal macrophages. FEMS Immunol Med Microbiol (1994) 0.78
Secretory carcinoma of the breast. Report of a case with diagnosis by fine needle aspiration. Acta Cytol (1992) 0.78
Epidermal growth factor receptor ligands in murine models for erythropoietic protoporphyria: potential novel players in the progression of liver injury. Cell Mol Biol (Noisy-le-grand) (2009) 0.77
A probiotic strain of Lactobacillus plantarum stimulates lymphocyte responses in immunologically intact and immunocompromised mice. Int J Food Microbiol (2006) 0.77
Degradation of o-methoxybenzoate by a two-member consortium made up of a gram-positive Arthrobacter strain and a gram-negative Pantotea strain. Biodegradation (2000) 0.77
Effects of concentrated supernatants recovered from Lactobacillus plantarum on Escherichia coli growth and on the viability of a human promyelocytic cell line. J Appl Microbiol (2009) 0.77
Cell proliferation activity and kinetic profile in the prognosis and therapeutic management of carcinoma of the pharynx and larynx. Otolaryngol Head Neck Surg (1999) 0.77
Comparison of ceftriaxone, amikacin, and ciprofloxacin in treatment of experimental Yersinia enterocolitica O9 infection in mice. Antimicrob Agents Chemother (1998) 0.77
Quantitative immunohistochemical analyses of the expression of E-cadherin, thrombomodulin, CD44H and CD44v6 in primary tumours of pharynx/larynx squamous cell carcinoma and their lymph node metastases. Anal Cell Pathol (1999) 0.77
Modification of acquired immunity in mice by imipenem/cilastatin. J Antimicrob Chemother (1999) 0.76
Experimental infection of mice with Yersinia enterocolitica serotype O9 by oral and parenteral routes: spreading and enterotropism of virulent yersiniae. Curr Microbiol (1999) 0.76
Saikosaponins from roots of Bupleurum gibraltaricum and Bupleurum spinosum. Phytochemistry (2000) 0.76
Inhibition of beta-lactamases from Yersinia enterocolitica by plant extracts. J Antimicrob Chemother (1987) 0.75
Synergistic effects of dicloxacillin or clavulanic acid in combination with penicillin G or cephalothin against Yersinia enterocolitica. Antimicrob Agents Chemother (1986) 0.75
[Glasses in XV century Spanish art (i)]. Arch Soc Esp Oftalmol (2012) 0.75
[Mixed hepatoblastoma in an adult]. Rev Esp Enferm Apar Dig (1987) 0.75
Streptococcus agalactiae: prevention and vaccine development. Rev Esp Quimioter (2017) 0.75
[The three most important books on ophthalmology from the 20th century]. Arch Soc Esp Oftalmol (2007) 0.75
Fine needle aspiration of sclerosing lymphocytic lobulitis of the breast. A report of two cases. Acta Cytol (1998) 0.75
Effect of the combination of clavulanic acid and cephalothin on an experimental infection with Yersinia enterocolitica in iron-overloaded mice. J Antimicrob Chemother (1988) 0.75
Clinical interest of Streptococcus bovis isolates in urine. Rev Esp Quimioter (2016) 0.75
Comparative flow cytometric analysis of DNA-bound PCNA and DNA content as estimators of S-phase cells in cell cultures. Anal Cell Pathol (1996) 0.75
Effects of aztreonam on natural immunity in mice. Int J Antimicrob Agents (1999) 0.75
[Immunomodulating activity of the genus Myxococcus]. Microbiol Esp (1985) 0.75
[Prolonged fever caused by toxoplasmosis]. Aten Primaria (1989) 0.75
Yersinia enterocolitica serotype O:3 is arthritogenic for mice. Microb Pathog (1990) 0.75
[Abscesses of the large intestine caused by a fish bone. Considerations apropos of 3 cases]. Rev Esp Enferm Apar Dig (1980) 0.75
Modulation of antibody-forming cell and mitogen-driven lymphoproliferative responses by dietary nucleotides in mice. Immunol Lett (1996) 0.75
[Pulmonary granulomatous arteritis caused by microembolism of foreign body]. Rev Clin Esp (1978) 0.75
[Antimicrobial activity against Yersinia enterocolitica in higher plants]. Microbiol Esp (1986) 0.75
Ploidy analysis on Wilms' tumour touch imprints using ethidium bromide and automated image analysis integrated confocal laser scanning microscopy. Virchows Arch (1995) 0.75
[Eyeglasses in XV century Spanish art (II)]. Arch Soc Esp Oftalmol (2013) 0.75
Immunomodulation in mice by Bacillus megaterium and its dependence on culture conditions. Immunol Lett (1981) 0.75
Disappearance of DNA HPV in sequential specimens of occult cervical infection in a "normal" population. Eur J Gynaecol Oncol (1996) 0.75
[Report on Spanish ophthalmology presented in the 1st Ophthalmology Congress (Brussels, 1857)]. Arch Soc Esp Oftalmol (2013) 0.75
[Generalized lymphadenopathy with morphologic findings of multicentric angiofollicular ganglionic hyperplasia in a patient with AIDS]. Rev Clin Esp (1993) 0.75
[Use of the Granada media and quality control of culture media]. Enferm Infecc Microbiol Clin (2000) 0.75
Cell proliferation activity and prognostic index in squamous cell lung carcinoma. Anal Cell Pathol (1998) 0.75
Modification of acquired immunity in BALB/c mice by aztreonam. Int J Antimicrob Agents (2000) 0.75
[Asthma and hyperthyroidism: a dangerous association]. An Med Interna (1990) 0.75
Modification of natural immunity in mice by imipenem/cilastatin. J Antibiot (Tokyo) (1997) 0.75
Induction of hepatic aminolevulinate acid synthetase activity by isoflurane in a genetic model for erythropoietic protoporphyria. Cell Mol Biol (Noisy-le-grand) (2009) 0.75
Yersinia enterocolitica serotype 0:3-induced arthritis in mice: microbiological and histopathological information. APMIS (1992) 0.75
[Regression of a choroidal metastasis from prostate adenocarcinoma after hormonal therapy]. Arch Soc Esp Oftalmol (2007) 0.75
Lignans from the wood of Abies pinsapo. J Nat Prod (1994) 0.75
[Pleural effusion due to Parvimonas micra. A case report and a literature review of 30 cases]. Rev Esp Quimioter (2017) 0.75
Performance of thiophilic adsorption chromatography in the purification of rat IgG2b monoclonal antibodies from serum- and protein-free culture supernatants. Biomed Chromatogr (1999) 0.75
[Several ophthalmologic references in Spanish literature in the beginning of the 20th century]. Arch Soc Esp Oftalmol (2009) 0.75
Synergy of clavulanic acid with benzylpenicillin or cephalothin against Yersinia spp. J Antimicrob Chemother (1987) 0.75
[Strongyloidiasis in an immunodepressed patient]. Rev Esp Enferm Apar Dig (1988) 0.75
Quantitative pathology of the cervical intraepithelial neoplasia. Eur J Gynaecol Oncol (1993) 0.75
[Ophthalmology in the Treatise of surgical operations by Martín Martínez]. Arch Soc Esp Oftalmol (2010) 0.75
Immunomodulation by myxospores of Myxococcus xanthus. J Gen Microbiol (1985) 0.75
[Street vendor glasses]. Arch Soc Esp Oftalmol (2013) 0.75
[First eyeglasses in paintings and miniatures of the 14th century]. Arch Soc Esp Oftalmol (2007) 0.75
[Hepatosplenic silicosis]. Rev Clin Esp (1974) 0.75
[Serum BCM in patients with nontumorous diseases. Preliminary results]. Rev Clin Esp (1990) 0.75